
Shree Ganesh Remedies Ltd Sees Bullish Momentum Amid Technical Upgrades
2026-08-04 08:09:27Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Sell to Hold as of 20 May 2026. The stock’s recent price action and technical indicators suggest a transition from a mildly bullish to a more confident bullish trend, signalling potential opportunities for investors amid a mixed broader market backdrop.
Read full news article
Shree Ganesh Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-03 08:03:14Shree Ganesh Remedies Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early August 2026. Despite a recent downgrade in daily price performance, the stock’s mixed signals from key technical indicators such as MACD, RSI, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Shree Ganesh Remedies Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-07-31 08:02:39Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. This change is underpinned by strong signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, signalling renewed investor interest and potential for further price appreciation.
Read full news article
Shree Ganesh Remedies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-07-29 08:03:47Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. Despite a recent decline in price, the stock’s mixed technical indicators present a nuanced outlook for investors navigating this evolving landscape.
Read full news article
Shree Ganesh Remedies Ltd is Rated Hold
2026-07-26 10:10:03Shree Ganesh Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Shree Ganesh Remedies Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-07-23 08:04:29Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, signalling renewed investor interest in this micro-cap pharmaceutical stock.
Read full news article
Shree Ganesh Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-21 08:06:32Shree Ganesh Remedies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, the stock’s technical indicators present a complex picture, reflecting both optimism and caution within the Pharmaceuticals & Biotechnology sector.
Read full news article
Shree Ganesh Remedies Ltd is Rated Hold
2026-07-15 10:10:06Shree Ganesh Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Shree Ganesh Remedies Ltd Valuation Shifts Amid Strong Market Performance
2026-07-09 08:01:14Shree Ganesh Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that have outpaced the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with industry peers, and assesses the implications for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Jul-2026 | Source : BSECertificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
Clarification On Price Movement
29-Jun-2026 | Source : BSEClarification
Compliances-Reg.24(A)-Annual Secretarial Compliance
25-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23






